Stephen P. Carey sold $285K of ANI Pharmaceuticals (ANIP)

Executed Jul 2, disclosed Jul 7, 4 days later.

Value, as filed

$285K

3,313 sh × $86.00

Executed

Jul 2

the trade date, as filed

Disclosed

Jul 7

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Stephen P. Carey SVP & CFO profile →

Stephen P. Carey (SVP & CFO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $552K of ANIP (7,312 sh across 2 lots, as filed), executed Mar 5.

The name

ANIP

ANI Pharmaceuticals, Inc. ANIP · Healthcare · 47 filings in 24 months ticker →

Healthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Stephen P. Carey in ANIP

ANIPSALE ANI Pharmaceuticals, Inc. $207K
2,850 sh × $72.80
Exec Aug 31
Filed Sep 1 · 6:18 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $232K
2,850 sh × $81.36
Exec Jul 29
Filed Jul 30 · 4:02 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $240K
2,850 sh × $84.12
Exec Jun 29
Filed Jun 30 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $265K
3,312 sh × $80.00
Exec Jun 5
Filed Jun 9 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $552K
7,312 sh across 2 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $4.3M
50,000 sh × $86.07
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $418K
7,500 sh × $55.79
Exec Dec 17 2024
Filed Dec 18 2024 · 5:30 PM ET